HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Benjamin P. Bidstrup Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Bidstrup, B. P. Search for Related Content PubMed Articles by Bidstrup, B. P. Related Collections Related Article

Ann Thorac Surg 1999;67:1016-1017
© 1999 The Society of Thoracic Surgeons

---

Commentary

^a Townsville General Hospital, Townsville, Queensland, Australia 4810

e-mail: bbidstrup@mailbox.uq.edu.au

Invited commentary

Point-of-care analytic devices must be evaluated in the clinical environment and compared with currently available methods as well as a gold standard. Anticoagulation monitoring in cardiovascular procedures lends itself to this technology, as it produces a timely result and usually requires no specialized preparation of the sample. In this study, which regrettably suffers from a lack of numbers, the authors have tested a new device, the Thrombolytic Assessment System Heparin Management Test (TAS HMT) (Pharmanetics Inc, Raleigh, NC) . . . [Full Text of this Article]

Related Article

Assessment of heparin anticoagulation: comparison of two commercially available methods

Hanne I. Flom-Halvorsen, Eivind Øvrum, Michel Abdelnoor, Stine Bjørnsen, and Frank Brosstad
Ann. Thorac. Surg. 1999 67: 1012-1016. [Abstract] [Full Text] [PDF]